In this study, 2.5% of a cohort of over 2200 ALS patients tested through a commercial laboratory had 31 or more repeats in ATXN2 and 0.4% had 34 or more [1]. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.